Roberto Colombo
Research Subjects
Roberto Colombo has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Agostino Colli
Department of Internal Medicine, Ospedale Alessandro Manzoni, Lecco, Italy
2 shared publications - Chiara Redaelli
Department of Psychology, Catholic University of the Sacred Heart, Milan, Italy
2 shared publications Daniela Tavian
Catholic University of the Sacred Heart
2 shared publications- Daniela Tavian
Laboratory of Cellular Biochemistry and Molecular Biology, CRIBENS, Catholic University of the Sacred Heart, Milan, Italy
2 shared publications - Daniele Prati
Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
2 shared publications - Donatella Mela
Department of Internal Medicine, Santa Corona Hospital, Pietra Ligure, Italy
2 shared publications
Latest Publications
- 4 April 2019
- Published by Elsevier in Journal of Hepatology
- Vol. 71 (2) , 366-370
Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations
- 4 April 2019
- Published by Elsevier in Journal of Hepatology
- Vol. 71 (2) , 366-370
Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations
- 1 September 2017
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 216, 269-271
A STAG3 missense mutation in two sisters with primary ovarian insufficiency
- 1 September 2017
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 216, 269-271
A STAG3 missense mutation in two sisters with primary ovarian insufficiency
- 27 January 2017
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 37 (3) , 404-405
TLR2 polymorphism and susceptibility to vulvovaginal colonisation by Candida species
(2017). TLR2 polymorphism and susceptibility to vulvovaginal colonisation by Candida species. Journal of Obstetrics and Gynaecology: Vol. 37, No. 3, pp. 404-405.
- 27 January 2017
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 37 (3) , 404-405
TLR2 polymorphism and susceptibility to vulvovaginal colonisation by Candida species
(2017). TLR2 polymorphism and susceptibility to vulvovaginal colonisation by Candida species. Journal of Obstetrics and Gynaecology: Vol. 37, No. 3, pp. 404-405.
- Open Access
- 21 February 2011
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 6 (1) , 6
Erratum To:Clinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene
- 21 February 2011
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 6 (1) , 6
Open AccessErratum To:Clinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene
- Open Access
- 1 December 2010
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 5 (1) , 33
Clinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene
Background: Chanarin-Dorfman syndrome (CDS) is a rare autosomal recessive disorder characterized by nonbullous congenital ichthyosiform erythroderma (NCIE) and an intracellular accumulation of triacylglycerol (TG) droplets in most tissues. The clinical phenotype involves multiple organs and systems, including liver, eyes, ears, skeletal muscle and central nervous system (CNS). Mutations in ABHD5/CGI58 gene are associated with CDS. Methods: Eight CDS patients belonging to six different families from Mediterranean countries were enrolled for genetic study. Molecular analysis of the ABHD5 gene included the sequencing of the 7 coding exons and of the putative 5' regulatory regions, as well as reverse transcript-polymerase chain reaction analysis and sequencing of normal and aberrant ABHD5 cDNAs. Results: Five different mutations were identified, four of which were novel, including two splice-site mutations (c.47+1G>A and c.960+5G>A) and two large deletions (c.898_*320del and c.662-1330_773+46del). All the reported mutations are predicted to be pathogenic because they lead to an early stop codon or a frameshift producing a premature termination of translation. While nonsense, missense, frameshift and splice-site mutations have been identified in CDS patients, large genomic deletions have not previously been described. Conclusions: These results emphasize the need for an efficient approach for genomic deletion screening to ensure an accurate molecular diagnosis of CDS. Moreover, in spite of intensive molecular screening, no mutations were identified in one patient with a confirmed clinical diagnosis of CDS, appointing to genetic heterogeneity of the syndrome.
- 1 December 2010
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 5 (1) , 33
Open AccessClinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene
Background: Chanarin-Dorfman syndrome (CDS) is a rare autosomal recessive disorder characterized by nonbullous congenital ichthyosiform erythroderma (NCIE) and an intracellular accumulation of triacylglycerol (TG) droplets in most tissues. The clinical phenotype involves multiple organs and systems, including liver, eyes, ears, skeletal muscle and central nervous system (CNS). Mutations in ABHD5/CGI58 gene are associated with CDS. Methods: Eight CDS patients belonging to six different families from Mediterranean countries were enrolled for genetic study. Molecular analysis of the ABHD5 gene included the sequencing of the 7 coding exons and of the putative 5' regulatory regions, as well as reverse transcript-polymerase chain reaction analysis and sequencing of normal and aberrant ABHD5 cDNAs. Results: Five different mutations were identified, four of which were novel, including two splice-site mutations (c.47+1G>A and c.960+5G>A) and two large deletions (c.898_*320del and c.662-1330_773+46del). All the reported mutations are predicted to be pathogenic because they lead to an early stop codon or a frameshift producing a premature termination of translation. While nonsense, missense, frameshift and splice-site mutations have been identified in CDS patients, large genomic deletions have not previously been described. Conclusions: These results emphasize the need for an efficient approach for genomic deletion screening to ensure an accurate molecular diagnosis of CDS. Moreover, in spite of intensive molecular screening, no mutations were identified in one patient with a confirmed clinical diagnosis of CDS, appointing to genetic heterogeneity of the syndrome.
- 14 April 2009
- Published by Springer Nature in neurogenetics
- Vol. 10 (4) , 313-318
Recent origin and spread of a common Welsh MAPT splice mutation causing frontotemporal lobar degeneration
IVS10+16C>T is the most prevalent mutation in the microtubule-associated protein tau gene (MAPT) causing frontotemporal lobar degeneration (FTLD) in populations of British descent. A highly conserved 17q21 haplotype was identified in IVS10+16C>T chromosomes from North Wales, Greater Manchester and the London areas of the UK, Australia, and the USA, suggesting the occurrence of a common founder effect. To test this hypothesis, the age of the mutation was estimated by parametric and Bayesian analysis of linkage disequilibrium's decay over generations, and the results were compared with historical and geographical data on FTLD families. The inferred age (23 generations; 95% confidence interval, 9–74 generations) dates the most recent common ancestor of IVS10+16C>T chromosomes before Welsh people started emigrating to the USA and Australia, where they introduced the mutation. The identification of a cohort of FTLD families with a homogeneous genetic background within and around the MAPT locus will further the investigation of the different clinical and pathological presentations of patients with identical MAPT mutations.
- 14 April 2009
- Published by Springer Nature in neurogenetics
- Vol. 10 (4) , 313-318
Recent origin and spread of a common Welsh MAPT splice mutation causing frontotemporal lobar degeneration
IVS10+16C>T is the most prevalent mutation in the microtubule-associated protein tau gene (MAPT) causing frontotemporal lobar degeneration (FTLD) in populations of British descent. A highly conserved 17q21 haplotype was identified in IVS10+16C>T chromosomes from North Wales, Greater Manchester and the London areas of the UK, Australia, and the USA, suggesting the occurrence of a common founder effect. To test this hypothesis, the age of the mutation was estimated by parametric and Bayesian analysis of linkage disequilibrium's decay over generations, and the results were compared with historical and geographical data on FTLD families. The inferred age (23 generations; 95% confidence interval, 9–74 generations) dates the most recent common ancestor of IVS10+16C>T chromosomes before Welsh people started emigrating to the USA and Australia, where they introduced the mutation. The identification of a cohort of FTLD families with a homogeneous genetic background within and around the MAPT locus will further the investigation of the different clinical and pathological presentations of patients with identical MAPT mutations.
- 9 February 2007
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (8) , 956-958
Improved cytochemical method for detecting Jordans’ bodies in neutral lipid storage diseases
Neutral lipid storage diseases (NLSDs) are a clinically heterogeneous group of non-lysosomal inherited disorders characterized by a cytoplasmic accumulation of lipid droplets (LDs) in most tissues. Rather than being an inert lipid inclusion, an impression given prima facie by their simple morphological structure under the light microscope, LDs were recently shown to be distinct organelles consisting of a core of neutral lipids, predominantly triacylglycerols or cholesteryl esters, that are surrounded by a monolayer of phospholipids and associated proteins.1,2 LDs take active part in lipid metabolism as well as in membrane trafficking and other cell fuctions.3
- 9 February 2007
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (8) , 956-958
Improved cytochemical method for detecting Jordans’ bodies in neutral lipid storage diseases
Neutral lipid storage diseases (NLSDs) are a clinically heterogeneous group of non-lysosomal inherited disorders characterized by a cytoplasmic accumulation of lipid droplets (LDs) in most tissues. Rather than being an inert lipid inclusion, an impression given prima facie by their simple morphological structure under the light microscope, LDs were recently shown to be distinct organelles consisting of a core of neutral lipids, predominantly triacylglycerols or cholesteryl esters, that are surrounded by a monolayer of phospholipids and associated proteins.1,2 LDs take active part in lipid metabolism as well as in membrane trafficking and other cell fuctions.3
- 1 March 2004
- Published by Springer Nature in Human Genetics
- Vol. 114 (4) , 366-376
Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis
The 1278insTATC is the most prevalent β-hexosaminidase A (HEXA) gene mutation causing Tay-Sachs disease (TSD), one of the four lysosomal storage diseases (LSDs) occurring at elevated frequencies among Ashkenazi Jews (AJs). To investigate the genetic history of this mutation in the AJ population, a conserved haplotype (D15S981:175–D15S131:240–D15S1050:284–D15S197:144–D15S188:418) was identified in 1278insTATC chromosomes from 55 unrelated AJ individuals (15 homozygotes and 40 heterozygotes for the TSD mutation), suggesting the occurrence of a common founder. When two methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for the study of the decay of LD over time, the estimated age of the insertion was found to be 40±12 generations (95% confidence interval: 30–50 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 8th–9th century. This corresponds with the demographic expansion of AJs in central Europe, following the founding of the Ashkenaz settlement in the early Middle Ages. The results are consistent with the geographic distribution of the main TSD mutation, 1278insTATC being more common in central Europe, and with the coalescent times of mutations causing two other LSDs, Gaucher disease and mucolipidosis type IV. Evidence for the absence of a determinant positive selection (heterozygote advantage) over the mutation is provided by a comparison between the estimated age of 1278insTATC and the probability of the current AJ frequency of the mutant allele as a function of its age, calculated by use of a branching-process model. Therefore, the founder effect in a rapidly expanding population arising from a bottleneck provides a robust parsimonious hypothesis explaining the spread of 1278insTATC-linked TSD in AJ individuals.
- 1 March 2004
- Published by Springer Nature in Human Genetics
- Vol. 114 (4) , 366-376
Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis
The 1278insTATC is the most prevalent β-hexosaminidase A (HEXA) gene mutation causing Tay-Sachs disease (TSD), one of the four lysosomal storage diseases (LSDs) occurring at elevated frequencies among Ashkenazi Jews (AJs). To investigate the genetic history of this mutation in the AJ population, a conserved haplotype (D15S981:175–D15S131:240–D15S1050:284–D15S197:144–D15S188:418) was identified in 1278insTATC chromosomes from 55 unrelated AJ individuals (15 homozygotes and 40 heterozygotes for the TSD mutation), suggesting the occurrence of a common founder. When two methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for the study of the decay of LD over time, the estimated age of the insertion was found to be 40±12 generations (95% confidence interval: 30–50 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 8th–9th century. This corresponds with the demographic expansion of AJs in central Europe, following the founding of the Ashkenaz settlement in the early Middle Ages. The results are consistent with the geographic distribution of the main TSD mutation, 1278insTATC being more common in central Europe, and with the coalescent times of mutations causing two other LSDs, Gaucher disease and mucolipidosis type IV. Evidence for the absence of a determinant positive selection (heterozygote advantage) over the mutation is provided by a comparison between the estimated age of 1278insTATC and the probability of the current AJ frequency of the mutant allele as a function of its age, calculated by use of a branching-process model. Therefore, the founder effect in a rapidly expanding population arising from a bottleneck provides a robust parsimonious hypothesis explaining the spread of 1278insTATC-linked TSD in AJ individuals.